Epithelial Nonepidermoid Neoplasms: Part I
The WHO classification of the epithelial nonepidermoid tumors includes the following conditions:
Benign epithelial (nonepidermoid) tumors
Salivary gland type adenomas
Pleomorphic adenoma ICD-O 8940/0
Myoepithelioma ICD-O 8982/0
Oncocytoma ICD-O 8290/0
Respiratory epithelial adenomatoid hamartoma; no ICD-O
Malignant epithelial (nonepidermoid) tumors
Adenocarcinoma
Intestinal-type adenocarcinomas ICD-O 8144/3
Sinonasal nonintestinal type adenocarcinomas ICD-0 8140/3
Salivary gland type carcinoma
Adenoid cystic carcinoma ICD-O 8200/3
Acinic cell carcinoma ICD-O 8550/3
Mucoepidermoid carcinoma ICD-O 8430/3
Epithelial-myoepithelial carcinoma ICD-O 8562/3
Clear cell carcinoma ICD-O 8310/3
Myoepithelial carcinoma ICD-O 8982/3
Carcinoma ex pleomorphic adenoma ICD-O 8941/3
Benign Epithelial (Nonepidermoid) Tumors
Adenomas
Definition
(ICD-O code 8940/0)
Benign salivary gland type epithelial tumors of one or mixed cell type (monomorphic or pleomorphic).
Etiology
The etiology is unknown. There is no evidence to support an early suggestion that they arise from the vomeronasal organ,1 especially as glandular elements are found throughout the sinonasal tract.2 There is one report in the literature suggesting a relationship of a pleomorphic adenoma on the nasal septum with Epstein-Barr virus.3
Synonyms
First described by Billroth in 1859, pleomorphic adenomas have been referred to as complex or mixed adenomas.4 The first one described in the nose was probably by Eichler in 1898.5
Incidence
The lesion is rare in the sinonasal region, constituting around 5% of all glandular tumors. Pleomorphic adenomas are somewhat more common than monomorphic. However, between 1949 and 1974 only 40 cases were referred to the Armed Forces Institute of Pathology.6 Since 1971, ~ 60 sinonasal cases have been reported in the literature.7–40
Site
These lesions most often arise on the septum but they have been reported on the lateral wall on the inferior turbinate21,31 and within the sinuses (occasionally maxillary or ethmoids). They have also been reported on the columella,33 in the pterygopalatine fossa,16 and in the nasopharynx27,28 but are much more commonly encountered in minor salivary tissue on the palate.
Diagnostic Features
Clinical Features
Slow growth eventually produces unilateral nasal obstruction, occasionally epistaxis, or serosanguinous discharge, or produces a mass on the palate affecting denture fitting, but the lesions can achieve spectacular proportions if neglected (Fig. 7.1). In the series of Compagno and Wong6 the patient age range for sinonasal pleomorphic adenomas was 3 to 82 years, mean 42 years, with only a slight female preponderance in contrast to the situation in the major salivary glands where it is most frequent in women. In the 56 reported cases, the ages ranged from 5 to 67 years (mean 42.3 years) and the male-to-female ratio was 1.2:1. Fifty-two percent arose on the septum and 31% on the lateral wall (usually the inferior turbinate); one case affected the rostrum of the sphenoid, one the columella, and two the nasopharynx.
Imaging
The features are those of any benign unilateral solid mass and are not specific (Fig. 7.2).14 There can be some local excavation of adjacent bone on CT, but there is little if any active destruction.35,37 Calcified foci and irregular enhancement has been described on CT with contrast.17
The tumor may be multilobulated and better defined on MRI. Fat-suppressed contrast-enhanced T1-weighted (T1W) spin-echo images showed marked curvilinear enhancement with small unenhanced foci.17 In the 9 patients reported by Wu et al40 there was low intensity on T1W images but intermediate to high on T2W sequences.
Histological Features and Differential Diagnosis
Monomorphic adenomas can be divided into myoepithelial, basaloid, trabecular/tubular, or oncocytic.
The diagnosis of pleomorphic adenoma requires the demonstration of epithelial (glandular) and mesenchymal (or myoepithelial) components. It is usually a lobulated and circumscribed lesion composed of epithelial tissue mixed with mucoid, myxoid or chondroid material, but a true capsule is rarely present.15 Intranasal pleomorphic adenomas have a similar immunohistochemical profile to their counterparts in the major salivary glands that depends on the dominant phenotype of the tumor. Most of the epithelial components will express various cytokeratins, whereas the myoepithelial component will express smooth muscle actin, S100, GFAP, CD10, and p63.19,41–43 Very occasionally the myoepithelial component is such that the tumor is designated as a myoepithelioma, which carries a separate ICD code in the WHO classification (ICD-O 8982/0). This is an exceptionally rare tumor in the sinonasal region and is more often encountered in the parotid and palate. It may be regarded as part of the spectrum of pleomorphic adenomas, being benign but more likely to recur.
The most important differentiation for pleomorphic adenoma is from malignant glandular tumors such as adenoid cystic type, adenocarcinoma, and the occasional carcinoma ex pleomorphic or true malignant mixed tumor.
Natural History
The normal course is slow insidious growth with conformity of the adjacent anatomy. Occasionally malignant transformation has been reported, although it is possible in some cases that the tumor was undercalled ab initio. A 5% rate of change has been estimated in general.
Carcinoma Ex Pleomorphic Adenoma and Malignant Mixed Tumors
These extremely rare malignant variants can arise either within an existing pleomorphic adenoma or de novo. Only a handful of cases (<20) have been reported, mainly arising on the palate or septum.44–57 Although factors relating to the prognosis of these tumors elsewhere have been discussed46,54 it is not known whether they can be extrapolated to this site.
Treatment and Outcome
Complete surgical excision by whatever approach is appropriate and will cure benign sinonasal adenomas. In the Compagno and Wong series, 3 out of 31 that were followed up for 1 to 41 years recurred and all were controlled with further surgery.6 Therefore, in many instances, cure can now be accomplished by endonasal endoscopic surgery,19,20,22,24,27,29,30,36,38–40 although lateral rhinotomy, midfacial degloving, and even craniofacial approaches have been required in some instances. In our five cases, all underwent surgical excision (3 by lateral rhinotomy, 1 by craniofacial resection and 1 by endoscopic resection) and none has recurred with 48 to 204 months’ follow-up (Table 7.1).
In the reported malignant cases, wide local excision has been the primary treatment combined with radiotherapy in ~50% of cases, but despite this outcomes have been poor with <50% alive and well and the rest either dead of disease or alive with recurrence at the time of reporting. As there are fewer than 20 cases, it is difficult to make any objective comment about optimum treatment.
References
1. Stevenson H. Mixed tumour of the nasal septum. Ann Otol Rhinol Laryngol 1932;41:563–570 2. Tos M. Goblet cells and glands in the nose and paranasal sinuses. In: Proctor D, Andersen I, eds. The Nose: Upper Airway Physiology and the Atmospheric Environment. Amsterdam: Elsevier; 1982:99–144 3. Malinvaud D, Couloigner V, Badoual C, Halimi P, Bonfils P. Pleomorphic adenoma of the nasal septum and its relationship with Epstein-Barr virus. Auris Nasus Larynx 2006;33(4):417–421 4. Billroth T. Beobachtungen uber Gerschwulste der Speicheldrusen. Virchows Arch 1859;17:357–375 5. Eichler W. Adenom einen von der Nasenschleimhaut ausgehenden Polypen vortäuschend. Arch Laryngol 1898;7:134 6. Compagno J, Wong RT. Intranasal mixed tumors (pleomorphic adenomas): a clinicopathologic study of 40 cases. Am J Clin Pathol 1977;68(2):213–218 7. Majed MA. Pleomorphic adenoma of nasal septum. J Laryngol Otol 1971;85(9):975–976 8. Worthington P. Pleomorphic adenoma of the nasal septum. Br J Oral Surg 1977;14(3):245–252 9. Bergström B, Biörklund A. Pleomorphic adenoma of the nasal septum. Report of two cases. J Laryngol Otol 1981;95(2):179–181 10. Baraka ME, Sadek SA, Salem MH. Pleomorphic adenoma of the inferior turbinate. J Laryngol Otol 1984;98(9):925–928 11. Kamal SA. Pleomorphic adenoma of the nose: a clinical case and historical review. J Laryngol Otol 1984;98(9):917–923 12. Haberman RS II, Stanley DE. Pleomorphic adenoma of the nasal septum. Otolaryngol Head Neck Surg 1989;100(6):610–612 13. Freeman SB, Kennedy KS, Parker GS, Tatum SA. Metastasizing pleomorphic adenoma of the nasal septum. Arch Otolaryngol Head Neck Surg 1990;116(11):1331–1333 14. Clark M, Fatterpekar GM, Mukherji SK, Buenting J. CT of intranasal pleomorphic adenoma. Neuroradiology 1999;41(8):591–593 15. Jassar P, Stafford ND, MacDonald AW. Pleomorphic adenoma of the nasal septum. J Laryngol Otol 1999;113(5):483–485 16. Kanazawa T, Nishino H, Ichimura K. Pleomorphic adenoma of the pterygopalatine fossa: a case report. Eur Arch Otorhinolaryngol 2000;257(8):433–435 17. Motoori K, Takano H, Nakano K, Yamamoto S, Ueda T, Ikeda M. Pleomorphic adenoma of the nasal septum: MR features. AJNR Am J Neuroradiol 2000;21(10):1948–1950 18. Yiotakis I, Dinopoulou D, Ferekidis E, Manolopoulos L, Adamopoulos G. Pleomorphic adenoma of the nose. Rhinology 2001;39(1):55–57 19. Hirai S, Matsumoto T, Suda K. Pleomorphic adenoma in nasal cavity: immunohistochemical study of three cases. Auris Nasus Larynx 2002;29(3):291–295 20. London SD, Schlosser RJ, Gross CW. Endoscopic management of benign sinonasal tumors: a decade of experience. Am J Rhinol 2002;16(4):221–227 21. Unlu HH, Celik O, Demir MA, Eskiizmir G. Pleomorphic adenoma originated from the inferior nasal turbinate. Auris Nasus Larynx 2003;30(4):417–420 22. Kumagai M, Endo S, Koizumi F, Kida A, Yamamoto M. A case of pleomorphic adenoma of the nasal septum. Auris Nasus Larynx 2004;31(4):439–442 23. Mackle T, Zahirovic A, Walsh M. Pleomorphic adenoma of the nasal septum. Ann Otol Rhinol Laryngol 2004;113(3 Pt 1):210–211 24. Pasquini E, Sciarretta V, Frank G, et al. Endoscopic treatment of benign tumors of the nose and paranasal sinuses. Otolaryngol Head Neck Surg 2004;131(3):180–186 25. Tahlan A, Nanda A, Nagarkar N, Bansal S. Pleomorphic adenoma of the nasal septum: a case report. Am J Otolaryngol 2004;25(2):118–120 26. Narozny W, Kuczkowski J, Mikaszewski B. Pleomorphic adenoma of the nasal cavity: clinical analysis of 8 cases. Am J Otolaryngol 2005;26(3):218 27. Roh JL, Jung BJ, Rha KS, Park CI. Endoscopic resection of pleomorphic adenoma arising in the nasopharynx. Acta Otolaryngol 2005;125(8):910–912 28. Lee SL, Lee CY, Silver SM, Kuhar S. Nasopharyngeal pleomorphic adenoma in the adult. Laryngoscope 2006;116(7):1281–1283 29. Sciarretta V, Pasquini E, Frank G, et al. Endoscopic treatment of benign tumors of the nose and paranasal sinuses: a report of 33 cases. Am J Rhinol 2006;20(1):64–71 30. Karakus MF, Ozcan KM, Dere H. Endoscopic resection of pleomorphic adenoma of the nasal septum. Tumori 2007;93(3):300–301 31. Mercante G, Di Lella F, Corradi D, Rindi G, Oretti G, Ferri T. Endoscopic surgical treatment of pleomorphic adenoma of the inferior nasal turbinate. J Otolaryngol 2007;36(3):E12–E14 32. Uğuz MZ, Onal K, Demiray U, Ekinci N. Tumoral mass presenting in the nasomalar region arising from the lateral nasal wall: pleomorphic adenoma. Eur Arch Otorhinolaryngol 2007;264(11):1377–1379 33. Ceylan A, Celenk F, Poyraz A, Uslu S. Pleomorphic adenoma of the nasal columella. Pathol Res Pract 2008;204(4):273–276 34. Gana P, Masterson L. Pleomorphic adenoma of the nasal septum: a case report. J Med Case Reports 2008;2:349 35. Oztürk E, Sağlam O, Sönmez G, Cüce F, Haholu ACT. CT and MRI of an unusual intranasal mass: pleomorphic adenoma. Diagn Interv Radiol 2008;14(4):186–188 36. Sciandra D, Dispenza F, Porcasi R, Kulamarva G, Saraniti C. Pleomorphic adenoma of the lateral nasal wall: case report. Acta Otorhinolaryngol Ital 2008;28(3):150–153 37. Olajide TG, Alabi BS, Badmos BK, Bello OT. Pleomorphic adenoma of the lateral nasal wall—a case report. Niger Postgrad Med J 2009;16(3):227–229 38. Acevedo JL, Nolan J, Markwell JK, Thompson D. Pleomorphic adenoma of the nasal cavity: a case report. Ear Nose Throat J 2010;89(5):224–226 39. Ng T-Y, Tsai M-H, Tai C-J. Pleomorphic adenoma of nasal septum: a case report. B-ENT 2010;6(1):53–54 40. Wu F, Huang CC, Fu CH, Chen YL, Lee TJ. Transnasal endoscopic surgery for intranasal pleomorphic adenomas. B-ENT 2010;6(1):43–47 41. Erlandson RA, Cardon-Cardo C, Higgins PJ. Histogenesis of benign pleomorphic adenoma (mixed tumor) of the major salivary glands. An ultrastructural and immunohistochemical study. Am J Surg Pathol 1984;8(11):803–820 42. Bilal H, Handra-Luca A, Bertrand JC, Fouret PJ. P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 2003;51(2):133–139 43. Eveson J, Kusafuka K, Stenman G, et al. Pleomorphic adenoma. In: Barnes L, Eveson J, Reichert P, Sidransky D, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005:254–258 44. Hjertman L, Eneroth CM. Tumours of the palate. Acta Otolaryngol Suppl 1969;263:179–182 45. Goepfert H, Luna MA, Lindberg RD, White AK. Malignant salivary gland tumors of the paranasal sinuses and nasal cavity. Arch Otolaryngol 1983;109(10):662–668 46. Tortoledo ME, Luna MA, Batsakis JG. Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch Otolaryngol 1984;110(3):172–176 47. Hellquist H, Michaels L. Malignant mixed tumour. A salivary gland tumour showing both carcinomatous and sarcomatous features. Virchows Arch A Pathol Anat Histopathol 1986;409(1):93–103 48. Cho KJ, el-Naggar AK, Mahanupab P, Luna MA, Batsakis JG. Carcinoma ex-pleomorphic adenoma of the nasal cavity: a report of two cases. J Laryngol Otol 1995;109(7):677–679 49. Freeman SR, Sloan P, de Carpentier J. Carcinoma expleomorphic adenoma of the nasal septum with adenoid cystic and squamous carcinomatous differentiation. Rhinology 2003;41(2):118–121 50. Chaudhry AP, Vickers RA, Gorlin RJ. Intraoral minor salivary gland tumors. An analysis of 1,414 cases. Oral Surg Oral Med Oral Pathol 1961;14:1194–1226 51. Bergman F. Tumors of the minor salivary glands. A report of 46 cases. Cancer 1969;23(3):538–543 52. Rafla S. Mucous gland tumors of paranasal sinuses. Cancer 1969;24(4):683–691 53. Frable WJ, Elzay RP. Tumors of minor salivary glands. A report of 73 cases. Cancer 1970;25(4):932–941 54. Spiro RH, Koss LG, Hajdu SI, Strong EW. Tumors of minor salivary origin. A clinicopathologic study of 492 cases. Cancer 1973;31(1):117–129 55. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu 1993;28(Pt 1):279–328 56. Chimona TS, Koutsopoulos AV, Malliotakis P, Nikolidakis A, Skoulakis C, Bizakis JG. Malignant mixed tumor of the nasal cavity. Auris Nasus Larynx 2006;33(1):63–66 57. Yazibene Y, Ait-Mesbah N, Kalafate S, et al. Degenerative pleomorphic adenoma of the nasal cavity. Eur Ann Otorhinolaryngol Head Neck Dis 2011;128(1):37–40Oncocytomas
Definition
(ICD-O code 8290/0)
An oncocytoma is an epithelial tumor composed of large cells containing a granular eosinophilic cytoplasm.
Etiology
Oncocytes are found in major and minor salivary glands and throughout the body in glandular tissue including adrenal, pituitary, thyroid, liver, pancreas, ovary, and stomach.1 In the head and neck, they have been found in the larynx, tonsillar fossa, and lacrimal gland.
Synonyms
Oxyphil adenoma, oncocytic cell adenoma, eosinophilic granular cell tumor have all been used for this rare lesion. Hamperl first used the term “oncocyte” in 1931 to describe large cells in major salivary glands filled with acidophilic granular cytoplasm.2 The first reference to an oncocytoma was by Gruenfeld and Jorsted in 1936.3
Incidence
These are rare lesions in the nose and sinuses with only around 30 reported as single case reports in the literature and account for <1% of all salivary gland tumors. We have only seen three cases in our cohort of 1,700 sinonasal tumors.
Site
Oncocytomas can occur on the septum or lateral nasal wall or within the maxillary and ethmoid sinuses (Table 7.2).4–24
Diagnostic Features
Clinical Features
Sinonasal oncocytomas occur equally in men and women, the reported age range being 12 to 84 years (mean 64 years), whereas elsewhere in the body they are more common in the elderly and in women.25 Two of our three patients were female. Patients present with nasal obstruction, nasal discharge, and epistaxis. More extensive and malignant lesions will produce tissue destruction with a visible swelling due to the mass breaking into the orbit or cheek together with associated epiphora, diplopia, proptosis, edema, and paresthesia.
Imaging
There are nonspecific features of a soft tissue mass with additional obstruction of adjacent sinuses and bone destruction depending on the aggressiveness of the lesion.
Histological Features and Differential Diagnosis
Oncocytomas are, as one might expect, composed of oncocytes which are large cuboidal or columnar cells with an abundant eosinophilic cytoplasm. This cytoplasm is particularly rich in mitochondria, which give it a granular appearance, and was first confirmed by electron microscopy.26 Lymphocytes are very rare within the tumor, which is positive for cytokeratin and epithelial membrane antigen but negative for S100. This must be distinguished from oncocytic metaplasia, which is not uncommon in the upper respiratory tract, oncocytic papillomas, and malignant oncocytomas, which are extremely rare. Oncocytic metaplasia may occur due to trauma or be a degenerative process. The other differential diagnoses include adenocarcinoma and adenoid cystic carcinoma.
There is no true capsule but compression of adjacent tissue may produce a “pseudo-capsule.”
In the major salivary glands, the benign forms are described as being papillary or cystic, whereas the more malignant appear solid.
Natural History
It is not known how many, if any, benign oncocytomas transform into a malignancy. However, as a general principle, tumors in minor salivary glands tend to be more aggressive than their counterparts in major glands and half of the reported tumors have acted in an aggressive fashion with locoregional recurrence10,18,23,24 and sometimes the demise of the patient.